Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020
Citation
AIHW
Australian Institute of Health and Welfare (2014) Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020, AIHW, Australian Government, accessed 18 July 2024.
APA
Australian Institute of Health and Welfare. (2014). Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020. Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020. AIHW, 2014.
Vancouver
Australian Institute of Health and Welfare. Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020. Canberra: AIHW; 2014.
Harvard
Australian Institute of Health and Welfare 2014, Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020, AIHW, Canberra.
PDF | 1.5Mb
End-stage kidney disease (ESKD) is the most severe form of chronic kidney disease with patients usually requiring kidney replacement therapy in the form of dialysis or kidney transplantation to survive. Projections of the prevalence of treated end-stage kidney disease in Australia presents national level projections of the number of people receiving kidney replacement therapy for their ESKD for the period 2012 to 2020. This information is important for predicting the future burden of ESKD in Australia.
- ISBN: 978-1-74249-578-1
- Cat. no: PHE 176
- Pages: 59
-
The number of people receiving Kidney Replacement Therapy (KRT) for ESKD tripled between 1991 and 2011
-
The prevalence of treated ESKD is projected to rise by between 45 and 64% between 2011 and 2020
-
The prevalence is projected to double for those who start treatment when they are over 75 years
-
The prevalence of treated-ESKD with diabetes as a primary cause is projected to double between 2011 and 2020